The ASX 200 fell 0.1pc on Thursday, led lower by Xero after XRO announced a $3.9b acquisition of US invoicing firm Melio Payments.

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.

Australia’s peak tech lobby group has signed a deal with its UK counterpart that means tech workers can more easily get jobs here.

A new report suggests institutional investors back lithium to recover from recent lows and miners and explorers position for ...

Xero slumped after unveiling a $3.9 billion Melio buyout funded by a cap raise, Neuren surged after landing a US patent for Pitt Hopkins drug ...

Property investors are already making widespread losses with inner-city apartments, now further tax pain is on the agenda.

Lynas CEO Amanda Lacaze says time is not right for a mega merger with MP Materials, which would create a "western champion" ...

US-based white hydrogen explorer HyTerra (ASX:HYT) selected the McCoy 1 well site based on geological understanding and ...

The ASX was struggling at midday, but soft CPI readings fuelled a banking stock rally to tip the market back into the green by end of trade.

Everest Metals (ASX:EMC) has confirmed an extensive regional gold trend that highlights the considerable scale of the Revere ...

Norwest Minerals (ASX:NWM) will launch a drilling campaign in mid-July to grow gold resources at its Bulgera project.

Singular Health (ASX:SHG) is shaping the future of medical imaging with its 3DICOM platform, hoping to improve ...